{
    "eid": "2-s2.0-85041097046",
    "title": "Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study",
    "cover-date": "2018-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Bortezomib",
        "Frontline",
        "Mantle cell lymphoma",
        "Phase 3"
    ],
    "authors": [
        "Johannes Drach",
        "Huiqiang Huang",
        "Olga Samoilova",
        "Andrew Belch",
        "Charles Farber",
        "Andr\u00e9 Bosly",
        "Jan Novak",
        "Jan Zaucha",
        "Angela Dascalescu",
        "Udomsak Bunworasate",
        "Zvenyslava Masliak",
        "Kateryna Vilchevskaya",
        "Tadeusz Robak",
        "Lixia Pei",
        "Brendan Rooney",
        "Helgi van de Velde",
        "Franco Cavalli"
    ],
    "citedby-count": 14,
    "ref-count": 24,
    "ref-list": [
        "Improvement of overall survival in advanced stage mantle cell lymphoma",
        "Mantle cell lymphoma: 2013 update on diagnosis, risk-stratification, and clinical management",
        "Transplantation for mantle cell lymphoma: Is it the right thing to do?",
        "Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",
        "Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis",
        "Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma",
        "The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status",
        "Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma",
        "Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia",
        "Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually",
        "Revised response criteria for malignant lymphoma",
        "Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: The BRIGHT study",
        "Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation",
        "Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group",
        "Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma",
        "Lenalidomide plus rituximab as initial treatment for mantle-cell lymphoma",
        "Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma",
        "Bortezomib in patients with relapsed or refractory mantle cell lymphoma: Updated time-to-event analyses of the multicenter phase 2 PINNACLE study",
        "Bortezomib for the treatment of mantle cell lymphoma",
        "Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma",
        "Phase 2 study of VcRCVAD with maintenance rituximab for untreated mantle cell lymphoma: An Eastern Cooperative Oncology Group study (E1405)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Lviv",
            "@id": "60275210",
            "affilname": "State Institution \u00abInstitute of Blood Pathology and Transfusion Medicine of National Academy of Medical Sciences of Ukraine\u00bb",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60275210",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60082502",
            "affilname": "Sun Yat-Sen University Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beerse",
            "@id": "60072269",
            "affilname": "Janssen Research &amp; Development",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072269",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Dinant",
            "@id": "60070063",
            "affilname": "CHU Dinant Godinne | UCL Namur",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070063",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Bellinzona",
            "@id": "60033277",
            "affilname": "Oncology Institute of Southern Switzerland",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033277",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Edmonton",
            "@id": "60030835",
            "affilname": "University of Alberta",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030835",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Titusville",
            "@id": "60027736",
            "affilname": "Janssen Pharmaceuticals, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027736",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "60027316",
            "affilname": "Takeda Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027316",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Prague",
            "@id": "60016605",
            "affilname": "Charles University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016605",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Gda\u0144sk",
            "@id": "60012383",
            "affilname": "Gdanski Uniwersytet Medyczny",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012383",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "60011394",
            "affilname": "Medizinische Universit\u00e4t Wien",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011394",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Nizhny Novgorod",
            "@id": "60008673",
            "affilname": "Lobachevsky State University of Nizhni Novgorod",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008673",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Lodz",
            "@id": "60006651",
            "affilname": "Medical University of Lodz",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006651",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Donetsk",
            "@id": "120143490",
            "affilname": "Institute of Urgent and Recovery Surgery n.a V.K. Gusaka of AMS of Ukraine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120143490",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "Morristown",
            "@id": "100712314",
            "affilname": "Carol G. Simon Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100712314",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Janssen Research and Development, LLC"
    ]
}